Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Guillermo Hönig"'
Autor:
Alejo, Corrales, Manuel, Vilapriño Duprat, Carlos, Benavente Pinto, Cristian, Garay, Ricardo, Corral, Pedro R, Gargoloff, Aníbal, Goldchluk, Guillermo, Hönig, Gabriela, Jufe, Fabián, Lamaison, Eduardo A, Leiderman, Carlos, Morra, Federico, Rebok, Pedro Damián, Gargoloff
Publikováno v:
Vertex (Buenos Aires, Argentina). (154)
Approximately 30% of people with schizophrenia fail to respond to first-line antipsychotic treatment which impacts the burden of the disease. Treatment-resistant schizophrenia (TRS) denotes patients with failure to respond to at least two adequate tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dba2d7ad1bd72add5299b5d6e48e51e9
https://pubmed.ncbi.nlm.nih.gov/35041733
https://pubmed.ncbi.nlm.nih.gov/35041733
Autor:
Guillermo, Hönig
Publikováno v:
Vertex (Buenos Aires, Argentina). (143)
30% of people with schizophrenia do not respond to antipsychotics. In these cases, treatment with clozapine is indicated, but only 40% of this subpopulation responds to treatment, thus forming a subgroup of resistant patients who do not respond to cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c0c75416d1c536843299c5f0cc356c31
https://pubmed.ncbi.nlm.nih.gov/31968029
https://pubmed.ncbi.nlm.nih.gov/31968029
Autor:
Demián Rodante, Facundo García Bournissen, Federico Manuel Daray, Joaquín Valentini, María Laura Gutiérrez, Guillermo Hönig, Silvia Wikinski, Mercedes Izaguirre, Mariela Lenze
Publikováno v:
Schizophrenia Bulletin
Background 30% patients suffering from schizophrenia fail to obtain therapeutic benefit even after two appropriate antipsychotic trials and are considered resistant. The recommended treatment in these cases is clozapine (CLZ), but only 40% of patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd2e37a7b9f90eb87ec7aa769b23b61
http://europepmc.org/articles/PMC7234559
http://europepmc.org/articles/PMC7234559